Improving the Sensitivity of a Novel PIM Kinase-Targeted Therapeutic Agent, CXR1002, Through Identification and Modulation of Cross-Talking Pathways (PhD Studentship)

  • Meek, David, (Investigator)
    StatusFinished
    Effective start/end date1/09/121/09/16